Clinical Treatment Score post-5 years as a predictor of late distant recurrence in hormone receptor-positive breast cancer: systematic review and meta-analysis

The Clinical Treatment Score post-5 years (CTS5) integrates four clinicopathological variables to estimate the residual disease recurrence risk in hormone receptor-positive breast cancer patients who have been treated with five years of adjuvant endocrine therapy. This study aimed to determine the a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of surgery 2022-04, Vol.109 (5), p.411-417
Hauptverfasser:	Shrestha, Amber, Cullinane, Carolyn, Evoy, Denis, Geraghty, James, Rothwell, Jane, Walshe, Janice, McCartan, Damien, McDermott, Enda, Prichard, Ruth
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antineoplastic Agents, Hormonal - therapeutic use Breast Neoplasms - drug therapy Female Humans Middle Aged Neoplasm Recurrence, Local - pathology Prognosis Receptors, Estrogen Risk Assessment Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!